Access the full text.
Sign up today, get DeepDyve free for 14 days.
T Darden, D York, L Pedersen (1983)
Particale mesh Ewald and N.log(N) method for Ewald sums in large systemsJ Chem Phys, 98
N Homeyer, H Gohlke (2012)
Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area methodMol Inf, 31
HM Berman, J Westbrook, Z Feng, G Gilliland, TN Bhat, H Weissig, IN Sh, IN dyalov, PE Bourne (2000)
The protein data bankNucleic Acids Res, 2
JC Gordon, JB Myers, T Folta, V Shoja, LS Heath, A Onufriev (2005)
H++: a server for estimating pKa’s and adding missing hydrogens to macromoleculesNucleic Acids Res, 33
A Fitton, RN Brogden (1994)
Pimobendan. a review of its pharmacology and therapeutic potential in congestive heart failureDrugs Aging, 4
J Ko, H Park, L Heo, C Seok (2012)
GalaxyWEB server for protein structure prediction and refinementNucleic Acids Res, 40
C Yang, S Zhang, P He, C Wang, J Huang, P Zhou (2015)
Self-binding peptides: folding or binding?J Chem Inf Model, 55
H Haikala, J Kaivola, E Nissinen, P Wall, J Levijoki, IB Lindén (1995)
Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendanJ Mol Cell Cardiol, 27
D Spoel, E Lindahl, B Hess, G Groenhof, AE Mark, HJ Berendsen (2005)
GROMACS: fast, flexible, and freeJ Comput Chem, 26
SP White, C Cohen, GN Phillips (2002)
Structure of co-crystals of tropomyosin and troponinNature, 325
I Bahar, TR Lezon, A Bakan, IH Shrivastava (2010)
Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteinsChem Rev, 110
JP Davis, SB Tikunova (2008)
Ca2+ exchange with troponin C and cardiac muscle dynamicsCardiovasc Res, 77
D Chen, S Liu, W Zhang, L Sun (2015)
Rational design of YAP WW1 domain-binding peptides to target TGFβ/BMP/Smad-YAP interaction in heterotopic ossificationJ Pept Sci, 21
MX Li, X Wang, BD Sykes (2004)
Structural based insights into the role of troponin in cardiac muscle pathophysiologyJ Muscle Res Cell Motil, 25
S Potluri, HO Ventura, M Mulumudi, MR Mehra (2004)
Cardiac troponin levels in heart failureCardiol Rev, 12
Y Sedan, O Marcu, S Lyskov, O Schueler-Furman (2016)
Peptiderive server: derive peptide inhibitors from protein-protein interactionsNucleic Acids Res, 44
WL Jorgensen, J Chandrasekhar, JD Madura, RW Impey, ML Klein (1983)
Comparison of simple potential functions for simulating liquid waterJ Phys Chem, 79
S Sharma, PG Jackson, J Makan (2004)
Cardiac troponinsJ Clin Pathol, 57
JM Word, SC Lovell, JS Richardson, DC Richardson (1999)
Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientationJ Mol Biol, 285
B Hess, H Bekker, HJC Berendsen, JGEM Fraaije (1997)
LINCS: A linear constraint solver for molecular simulationsJ Comput Chem, 18
H Yu, P Zhou, M Deng, Z Shang (2014)
Indirect readout in protein-peptide recognition: a different story from classical biomolecular recognitionJ Chem Inf Model, 54
N London, B Raveh, D Movshovitz-Attias, O Schueler-Furman (2010)
Can self-inhibitory peptides be derived from the interfaces of globular protein-protein interactions?Proteins, 78
The Ca2+-sensitive cardiac troponin (cTn) is a hetero-trimer complex consisting of three subunits cTnC, cTnI, and cTnT, which has been recognized as an important biomarker and a potential target of cardiovascular diseases. Previously, several small-molecule agents such as levosimendan and pimobendan have been successfully developed to target this protein for the treatment of heart failure. Here, instead of small-molecule chemical drugs, we purposed rational derivation of self-inhibitory peptides as potential biologic disruptors of cTnC–cTnI interaction from the interaction complex interface. In the procedure, the crystal structure of cTn trimer was examined in detail using bioinformatics approach, from which a peptide-mediated interaction between the N-terminal domain of cTnC and the switch region of cTnI was identified. The switch is a 19-mer peptide segment Swt that contains a structured helical core capped by a short N-terminal tripeptide and a disordered C-terminal tail. Structural and energetic analysis revealed that the Swt peptide binds independently to cTnC N-terminal domain, which can be stripped from the intact cTnI subunit to interact effectively with cTnC. Further investigations found that truncation of two N-terminal residues and five C-terminal residues of the full-length Swt peptide, resulting in a shortened version namely Swt-ΔN2ΔC5 peptide, would not cause substantial loss in its binding potency to cTnC. The computational finding was then confirmed by using fluorescence-based affinity assays; the Swt and Swt-ΔN2ΔC5 peptides was experimentally measured to have a moderately high affinity to the recombinant protein of human cTnC N-terminal domain with K d values at micromolar level. The Swt and Swt-ΔN2ΔC5 are considered as inhibitory peptides that can be further optimized and modified to obtain high-affinity disruptors of cTnI–cTnC interaction.
International Journal of Peptide Research and Therapeutics – Springer Journals
Published: Jan 25, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.